⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Lexaria Bioscience Corp. Common Stock

$2.94
+0.12 (+4.26%)

Volume:

10.487K ($30.74K)

Market Capitalization:

$6.19M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Lexaria Bioscience Corp. Market Segments

Regular Trading Hours

+0.20(+7.30%)
Open$2.74
Close$2.94
Low$2.74
Low Change0.00 (0.00%)
High$2.99
High Change+0.25 (+9.12%)
Range$0.25
Volume8.158K
Dollar Volume$23.98K

Premarket

-0.10(-3.33%)
Open$3.00
Close$2.90
Low$2.66
Low Change-0.34 (-11.33%)
High$3.00
High Change+0.00 (+0.00%)
Range$0.34
Volume2.329K
Dollar Volume$6.75K

Overnight

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.01(+0.36%)
Open$2.81
Close$2.82
Low$2.43
Low Change-0.38 (-13.52%)
High$2.92
High Change+0.11 (+3.90%)
Range$0.49
Volume100.248K
Dollar Volume$282.70K

Premarket Yesterday

+0.00(+0.00%)
Open$2.95
Close$2.95
Low$2.95
Low Change0.00 (0.00%)
High$2.95
High Change+0.00 (+0.00%)
Range$0.00
Volume109
Dollar Volume$321.55

Lexaria Bioscience Corp. News

There is no current news for this stock at the moment.

Lexaria Bioscience Corp. Top Trades

Lexaria Bioscience Corp.'s top trade so far today returned +12.41%, while the top short trade returned -11.33%.

Lexaria Bioscience Corp. Moving Averages

5 Day Moving Average (SMA5)$3.08
10 Day Moving Average (SMA10)$3.09
20 Day Moving Average (SMA20)$3.16
50 Day Moving Average (SMA50)$6.43
100 Day Moving Average (SMA100)$3.60
200 Day Moving Average (SMA200)$2.17

Lexaria Bioscience Corp. Statistics

Average Volume (30 Days)95.21K
P/E Ratio (Current)-.90
EPS (Current)-$3.67
Dividend Yield0.00%
Free Cash Flow-$7.47M
Cash Ratio9.06
Current Ratio10.60
Quick Ratio10.60
Debt to Equity0.00
Enterprise Value$3.52M
EV to EBITDA-0.46
EV to Sales18.14
Price to Book1.48
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales36.05
Return on Assets-1.62%
Return on Equity-1.63%

Lexaria Bioscience Corp. Stock Splits

There has been 1 stock split for Lexaria Bioscience Corp. (LEXX). The reverse stock split occured on August 3, 2026 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Aug 3, 2026Reverse15:1

Lexaria Bioscience Corp. Dividends

There have been no dividends for Lexaria Bioscience Corp. (LEXX).